A “rheostat” for cancer signals

• Read more about A “rheostat” for cancer signals

 

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

New prostate cancer treatment concept

• Read more about New prostate cancer treatment concept

Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

Grant strengthens breast cancer research efforts

• Read more about Grant strengthens breast cancer research efforts

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

Colorectal cancer researchers receive SPORE funding

• Read more about Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

New window on fibrosis

• Read more about New window on fibrosis

A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.